ALFA Finder| Revenue growth | 38.1% YoY |
|---|---|
| Margins | EBITDA margin at 24.2%; improved occupancy to 65.0%. |
| Demand visibility | Sustained patient demand; IP/OP volumes up 38.8% and 26.0%. |
| Management confidence | High; citing strength of Pan-India network and IPO flexibility. |
Growth
Revenue grew 38.1% YoY to ₹3,091 Cr; EBITDA increased 26.4% YoY to ₹749 Cr. PAT reached ₹243 Cr.
Outlook
Focusing on clinical integration of Sahyadri, expanding access, and investing in advanced technology like LINAC and surgical robots.
Risks
Integration complexities of Sahyadri acquisition and high debt levels (₹8,435 Cr net debt post-acquisition) are primary concerns.
Investor Presentation filed with NSE, NSE: MANIPALHOS. Summary written with AI assistance from the document.
Manipal Health Enterprises Ltd: key numbers
- Share price
- ₹674.25
- Market cap
- ₹88,689 Cr
- Revenue (annual)
- ₹10,336 Cr
- Net profit (annual)
- ₹892.3 Cr
- Promoter holding
- 72.08%
- FII holding
- 3.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Manipal Health Enterprises Ltd
All →Manipal Health Enterprises Capacity Expansion
Manipal Health Enterprises executed a 29-year-11-month land lease with TIL Investments to build and operate a hospital in Gurugram. No monetary value is disclosed.
- Execution
- 29 years 11 months
Manipal Health Enterprises Board Meeting Date
Manipal Health Enterprises gave notice that its board meets on 13 November 2026 to approve the Q2 and H1 FY27 standalone and consolidated unaudited results. This is advance intimation, and the agenda is proposed only.
Manipal Health Enterprises Legal & Regulatory
Manipal Health's subsidiary received two GST orders imposing penalties totalling about Rs 4.61 Crore. The company says the orders are appealable and the impact is not material.
- Value
- ₹4.61 Cr
Manipal Health Enterprises Legal & Regulatory
Manipal Health's subsidiary received GST orders confirming tax demands and penalties of about Rs 8.38 Crore. Company sees no material impact and will appeal.
- Value
- ₹8.38 Cr
Manipal Health Enterprises Share Pledge
Promoter entity MEMG International India Pvt Ltd released pledges over 72,50,000 and 72,42,951 shares of Manipal Health Enterprises. The 22 October 2026 release eases encumbrances in favour of Vistra ITCL and 360 One Prime.
Manipal Health Enterprises Other Announcement
This is a quarterly shareholding pattern filing for Manipal Health Enterprises Ltd for the quarter ended September 30, 2026, pursuant to Regulation 31(1)(b).